The world has faced a string of infectious disease threats in the past dozen or so years, with SARS, bird flu, swine flu, MERS, and Ebola wreaking havoc.
Yet despite the abundance of evidence that microbes pose major threats, both to human health and economies, global preparedness is not where it needs to be, Dr. Julie Gerberding warned this week.
Gerberding was a former director of the Centers for Disease Control and Prevention — a post she held during the 2003 SARS outbreak. She is now Merck’s executive vice-president for strategic communications, global health policy and population health.
About the Author Reprints
Let me guess- Merck happens to make compounds that one could use to treat these outbreaks- imagine! What happened to that rule about going o work for a company you used to regulate?